Fourace Industries Group Holdings Limited (1455.HK)
HKD 0.16
(1.25%)
HKD 0.16
(1.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 61.52 Million HKD | -38.82% |
| 2022 | 89.54 Million HKD | -6.02% |
| 2021 | 85.77 Million HKD | -12.89% |
| 2020 | 85.18 Million HKD | 44.54% |
| 2019 | 65.24 Million HKD | 27.47% |
| 2018 | 51.3 Million HKD | 16.81% |
| 2017 | 44.04 Million HKD | 1.09% |
| 2016 | 43.34 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | 21.85 Million HKD | -23.95% |
| 2023 Q4 | 23.93 Million HKD | 9.52% |
| 2023 FY | - HKD | -38.82% |
| 2022 FY | - HKD | -6.02% |
| 2022 Q2 | 48.48 Million HKD | 10.06% |
| 2022 Q4 | 28.73 Million HKD | -40.75% |
| 2021 Q2 | 38.1 Million HKD | -15.83% |
| 2021 Q4 | 44.05 Million HKD | 15.61% |
| 2021 FY | - HKD | -12.89% |
| 2020 Q2 | 49.04 Million HKD | 56.69% |
| 2020 FY | - HKD | 44.54% |
| 2020 Q4 | 45.27 Million HKD | -7.69% |
| 2019 FY | - HKD | 27.47% |
| 2019 Q4 | 31.29 Million HKD | -7.81% |
| 2019 Q2 | 33.95 Million HKD | 0.0% |
| 2018 FY | - HKD | 16.81% |
| 2017 FY | - HKD | 1.09% |
| 2016 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -168.527% |
| Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 80.637% |
| China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -2932.282% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 412.532% |
| Huasheng International Holding Limited | 19.67 Million HKD | -212.659% |
| Evergreen Products Group Limited | 140.78 Million HKD | 56.298% |
| EC Healthcare | 737.83 Million HKD | 91.661% |
| Ming Fai International Holdings Limited | 211.83 Million HKD | 70.956% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | 90.627% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 931.531% |
| Takbo Group Holdings Limited | 25.8 Million HKD | -138.432% |
| Hyfusin Group Holdings Limited | 154.18 Million HKD | 60.097% |